Angiotensin II receptor antagonist and thiazide diuretic
This page covers all Angiotensin II receptor antagonist and thiazide diuretic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Angiotensin II receptor.
Targets
Phase 3 pipeline (1)
- losartan + hydrochlorothiazide, if necessary · Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company · Cardiovascular
Losartan is an angiotensin II receptor antagonist that blocks the action of angiotensin II, a potent vasoconstrictor, to relax blood vessels and lower blood pressure. Hydrochlorothiazide is a thiazide diuretic that increases urine production to reduce blood pressure.
Patent intelligence
- angiotensin ii receptor antagonist and thiazide diuretic patent landscape — aggregated cliff calendar, attackable patents, originator estates